Biomedical and therapeutic applications of biosurfactants

Advances in Experimental Medicine and Biology

Volumn 672, Issue , 2010, Pages 75-87

  Rodrigues, Lígia R ^a   Teixeira, José A ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOSURFACTANT; GLYCOLIPID; LIPOPEPTIDE; RHAMNOLIPID; SURLACTIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; LIPOPROTEIN; SURFACTANT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS; BACTERIUM ADHERENCE; CANDIDA; HOSPITAL INFECTION; LACTOBACILLUS; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STREPTOCOCCUS; ANIMAL; BACTERIAL INFECTION; DRUG EFFECT; HUMAN; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BIOLOGICAL PRODUCTS; GLYCOLIPIDS; HUMANS; LIPOPROTEINS; SURFACE-ACTIVE AGENTS;

EID: 77954504195     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5979-9_6     Document Type: Article

References (116)

1. Morikawa M, Daido H, Takao T et al. A new lipopeptide biosurfactant produced by Arthrobacter sp. strain MIS38. J Bacteriol 1993; 175:6459-6466. (Pubitemid 23315477)
2. Lin S. Biosurfactants: Recent advances. J Chem Tech Biotechnol 1996; 66:109-120. (Pubitemid 26169281)
3. Desai JD, Banat IM. Microbial production of surfactants and their commercial potential. Microbiol Mol Biol Rev 1997; 61:47-64. (Pubitemid 27290924)
4. Angelova B, Schmauder H-P. Lipophilic compounds in biotechnology- interactions with cells and technological problems. J Biotechnol 1999; 67:13-32. (Pubitemid 29048319)
5. Ahimou F, Jacques P, Deleu M. Surfactin and iturin a effects on bacillus subtilis surface hydrophobicity. Enz Microb Technol 2001; 27:749-754.
6. Van Hamme JD, Singh A, Ward OP. Physiological aspects. Part 1 in a series of papers devoted to surfactants in microbiology and biotechnology. Biotech Adv 2006; 24:604-620. (Pubitemid 44499004)
7. Singh A, Van Hamme JD, Ward OP. Surfactants in microbiology and biotechnology: Part 2. Application aspects. Biotech Adv 2007; 25:99-121. (Pubitemid 46038038)
8. Kosaric N. Biosurfactants in industry. J Am Oil Chem Soc 1992; 64:1731-1737.
9. Cameotra S, Makkar R. Synthesis of biosurfactants in extreme conditions. Appl Microbiol Biotechnol 1998; 50:520-529. (Pubitemid 28555288)
10. Mukherjee S, Das P, Sen R. Towards commercial production of microbial surfactants. Trends Biotechnol 2006; 24:509-515. (Pubitemid 44540380)
11. Makkar R, Cameotra S. An update on the use of unconventional substrates for biosurfactant production and their new applications. Appl Microbiol Biotechnol 2002; 58:428-434. (Pubitemid 34232330)
12. Otto RT, Daniel H-J, Pekin G et al. Production of sophorolipids from whey II.-Product composition, surface active properties, cytotoxicity and stability against hydrolases by enzimatic treatment. Appl Microbiol Biotechnol 1999; 52:495-501. (Pubitemid 29513328)
13. Rodrigues LR, Teixeira JA, Oliveira R. Low cost fermentative medium for biosurfactant production by probiotic bacteria. Biochem Eng J 2006; 32:135-142. (Pubitemid 44751575)
14. Rodrigues LR, Moldes A, Teixeira JA et al. Kinetic study of fermentative biosurfactant production by lactobacillus strains. Biochem Eng J 2006; 28:109-116. (Pubitemid 43188908)
15. Das K, Mukherjee AK. Comparison of lipopeptide biosurfactants production by Bacillus subtilis strains in submerged and solid state fermentation systems using a cheap carbon source: Some industrial applications of biosurfactants. Process Biochem 2007; 42:1191-1199. (Pubitemid 47089063)
16. Joshi S, Bharucha C, Jha S et al. Biosurfactant production using molasses and whey under thermophilic conditions. Biores Technol 2008; 99:195-199. (Pubitemid 47503787)
17. Rivera OMP, Moldes AB, Torrado AM et al. Lactic acid and biosurfactants production from hydrolyzed distilled grap marc. Process Biochem 2007; 42:1010-1020. (Pubitemid 46702767)
18. Moldes AB, Torrado AM, Barral MT et al. Evaluation of biosurfactant production from various agricultural residues by lactobacillus pentosus. J Agr Food Chem 2007; 55:4481-4486. (Pubitemid 46932645)
19. Fiechter A. Biosurfactants: Moving towards industrial application. Trends Biotechnol 1992; 10:208-218.
20. Rodrigues LR, Teixeira JA, Oliveira R et al. Response surface optimization of the medium components for the production of biosurfactants by probiotic bacteria. Process Biochem 2006; 41:1-10. (Pubitemid 41785576)
21. Singh P, Cameotra S. Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol 2004; 22:142-146. (Pubitemid 38230393)
22. Banat IM. Biosurfactants production and use in microbial enhanced oil recovery and pollution remediation: A review. Biores Technol 1995; 51:1-12.
23. Banat IM. Biosurfactants characterization and use in pollution removal: State of the art. A review. Acta Biotechnol 1995; 15:25167.
24. Mulligan CN. Environmental application for biosurfactants. Environ Pollut 2005; 133:183-198.
25. Banat IM, Makkar R, Cameotra S. Potential commercial applications of microbial surfactants. Appl Microbiol Biotechnol 2000; 53:495-508. (Pubitemid 30341398)
26. Benincasa M, Abalos A, Oliveira I et al. Chemical structure, surface properties and biological activities of the biosurfactant produced by pseudomonas aeruginosa LB1 from soapstock. Antonie Van Leeuwenhoek 2004; 85:1-8. (Pubitemid 38461032)
27. Flasz A, Rocha CA, Mosquera B et al. A comparative study of the toxicity of a synthetic surfactant and one produced by Pseudomonas aeruginosa ATCC 55925. Med Sci Res 1998; 6:181-185. (Pubitemid 28149585)
28. Rodrigues LR, Banat IM, Teixeira JÁ et al. Biosurfactants: Potential applications in medicine. J Antimicrob Chemother 2006; 57:609-618.
29. Rodrigues LR, Banat IM, Teixeira JA et al. Strategies for the prevention of microbial biofilm formation on silicone rubber voice prostheses. J Biomed Mater Res B Appl Biomater 2007; 81B:358-370. (Pubitemid 46685103)
30. Maier RM. Biosurfactant: Evolution and diversity in bacteria. Adv Appl Microbiol 2003; 52:101-121.
31. Gerard J, Lloyd R, Barsby T et al. Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats. J Nat Prod 1997; 60:223-229. (Pubitemid 27146454)
32. Rodrigues LR, Banat IM, Van der Mei HC et al. Interference in adhesion of bacteria and yeasts isolated from explanted voice prostheses to silicone rubber by rhamnolipid biosurfactants. J Appl Microbiol 2005; 100:470-480.
33. Lang S, Wullbrandt D. Rhamnose lipids-biosynthesis, microbial production and application potential. Appl Microbiol Biotechnol 1999; 51:22-32. (Pubitemid 29066642)
34. Maier R, Soberon Chavez G. Pseudomonas aeruginosa rhamnolipids: Biosynthesis and potential applications. Appl Microbiol Biotechnol 2000; 54:625-633.
35. Das K, Mukherjee AK. Characterization of biochemical properties and biological activities of biosurfactants produced by pseudomonas aeruginosa mucoid and nonmucoid strains isolated from hydrocarbon- contaminated soil samples. Appl Microbiol Biotechnol 2005; 69:192-199. (Pubitemid 41795093)
36. Vollenbroich D, Pauli G, Ozel M et al. Antimycoplasma properties and applications in cell culture of surfactin, a lipopeptide antibiotic from bacillus subtilis. Appl Env Microbiol 1997; 63:44-49. (Pubitemid 27020367)
37. Vollenbroich D, Ozel M, Vater J et al. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from bacillus subtilis. Biologicals 1997; 25:289-297. (Pubitemid 27453251)
38. Kameda Y, Ouchira S, Matsui Kkanatomo S et al. Antitumor activity of bacillus natto V. Isolation and characterization of surfactin in the culture medium of bacillus natto KMD 2311. Chem Pharmacol Bull 1974; 22:938-944.
39. Bernheimer A, Avigad L. Nature and properties of a cytolytic agent produced by Bacillus subtilis. J Gen Microbiol 1970; 61:361-69.
40. Sheppard JD, Jumarie C, Cooper DG et al. Ionic channels induced by surfactin in plannar lipid bilayer membranes. Biochim Biophys Acta 1991; 1064:13-23.
41. Itokawa H, Miyashita T, Morita H et al. Structural and conformational studies of [Ile7] and [Leu7] surfactins from bacillus subtilis. Chem Pharmacol Bull 1994; 42:604-607. (Pubitemid 24156278)
42. Wang CL, Ng TB, Yuan F et al. Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from bacillus subtilis natto T-2. Peptides 2007; 28:1344-1350. (Pubitemid 47088750)
43. Dehghan Noudeh G, Housaindokht M, Bazzaz BSF. Isolation, characterization and investigation of surface and haemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtitlis ATCC 6633. J Microbiol 2005; 43:272-276. (Pubitemid 40993185)
44. Naruse N, Tenmyo O, Kobaru S et al. Pumilacidin, a complex of new antiviral antibiotics: Production, isolation, chemical properties, structure and biological activity. J Antibiot 1990; 43:267-280. (Pubitemid 20106390)
45. Besson F, Peypoux F, Michel G et al. Characterization of iturin A in antibiotics from various strains of Bacillus subtilis. J Antibiot 1976; 29:1043-1049.
46. Thimon L, Peypoux F, Wallach J et al. Effect of lipopeptide antibiotic, iturin A, on morphology and membrane ultrastructure of yeast cells. FEMS Microbiol Lett 1995; 128:101-106.
47. Tanaka Y, Takashi T, Kazuhik U et al. Method of producing iturin A and antifungal agent for profound mycosis. Biotechnol Adv 1997; 15:234-235.
48. Mittenbuhler K, Loleit M, Baier W et al. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro. Int J Immunopharmacol 1997; 19:277-287. (Pubitemid 27511507)
49. Jenny K, Kappeli O, Fietcher A. Biosurfactants from bacillus licheniformis: Structural analysis and characterization. Appl Microbiol Biotechnol 1991; 36:5-13.
50. Lin S, Carswell K, Sharma M. Continuous production of the lipopeptide biosurfactant of bacillus licheniformis JF-2. Appl Microbiol Biotechnol 1994; 41:281-285. (Pubitemid 24197112)
51. Yakimov M, Timmis K, Wray V et al. Characterization of a new lipopeptide surfactant produced by thermotolerant and halotolerant subsurface Bacillus licheniformis BAS50. Appl Env Microbiol 1995; 61:1706-1713.
52. Grangemard I, Wallach J, Maget Dana R et al. Lichenysin: A more efficient cation chelator than surfactin. Appl Biochem Biotechnol 2001; 90:199-210. (Pubitemid 32295758)
53. Kitamoto D, Yanagishita H, Shinbo T et al. Surface active properties and antimicrobial activities of mannosylerythritol lipids as biosurfactants produced by Candida antarctica. J Biotechnol 1993; 29:91-96.
54. Isoda H, Kitamoto D, Shinmoto H et al. Microbial extracellular glycolipid induction of differentiation and inhibition of protein kinase C activity of human promyelocytic leukaemia cell line HL60. Biosci Biotechnol Biochem 1997; 61:609-614. (Pubitemid 27312692)
55. Isoda H, Shinmoto H, Matsumura M et al. The neurite-initiating effect of microbial extracellular glycolipids in PC12 cells. Cytotechnol 1999; 31:163-170. (Pubitemid 29471582)
56. Shibahara M, Zhao X, Wakamatsu Y et al. Mannosylerythritol lipid increases levels of galactoceramide in and neutrite outgrowth from PC12 pheochromocytoma cells. Cytotechnol 2000; 33:247-251.
57. Zhao X, Geltinger C, Kishikawa S et al. Tretament of mouse melanoma cells with phorbol 12-myristate 13-acetate counteracts mannosylerythritol lipid-induced growth arrest and apoptosis. Cytotechnol 2000; 33:123-130.
58. Zhao X, Wakamatsu Y, Shibahara M et al. Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture. Cancer Res 1999; 59:482-486. (Pubitemid 29048887)
59. Wakamatsu Y, Zhao X, Jin C et al. Mannosylerythritol lipid induces characteristics of neuronal differentiation in PC12 cells through an ERK-related signal cascade. Eur J Biochem 2001; 268:374-383. (Pubitemid 32862668)
60. Ueno Y, Hirashima N, Inoh Y et al. Characterization of biosurfactant-containing liposomes and their efficiency for gene transfection. Biol Pharmaceut Bull 2007; 30:169-172. (Pubitemid 46066340)
61. Ueno Y, Inoh Y, Furuno T et al. NBD-conjugated biosurfactant (MEL-A) shows a new pathway for transfection. J Contr Release 2007; 123:247-253. (Pubitemid 350007821)
62. Shah V, Badia D, Ratsep P. Sophorolipids having enhanced antibacterial activity. Antimicrob Agents Chemother 2007; 51:397-400. (Pubitemid 46047741)
63. Maitani Y, Yano S, Hattori Y et al. Liposome vector containing biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene delivery system. J Liposome Res 2006; 16:359-372. (Pubitemid 44949886)
64. Konishi M, Imura T, Fukuoka T et al. A yeast glycolipid biosurfactant, mannosylerytritol lipid, shows high binding affinity towards lectins on a self-assembled monolayer system. Biotechnol Lett 2007; 29:473-480.
65. Ito S, Imura T, Fukuoka T et al. Kinetic studies on the interactions between glycolipid biosurfactant assembled monolayers and various classes of immunoglobulins using surface plasmon resonance. Colloids Surf B Biointerfaces 2007; 58:165-171. (Pubitemid 46921453)
66. Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Contr Release 2006; 112:362-368. (Pubitemid 43737151)
67. Uchida Y, Misava S, Nakahara T et al. Factor affecting the production of succinotrehalose lipids by rodococcus erythropolis SD-74 grown on n-alkanes. Agr Biol Chem 1989; 53:765-769.
68. Uchida Y, Tsuchiya R, Chino M et al. Extracellular accumulation of mono and di succinyl trehalose lipids by a strain of rodococcus erythropolis grown on n-alkanes. Agr Biol Chem 1989; 53:757-763.
69. Busscher HJ, Neu T, Van der Mei HC. Biosurfactant production by thermophilic dairy streptococci. Appl Microbiol Biotechnol 1994; 41:4-7. (Pubitemid 24107029)
70. Rodrigues LR, Van der Mei HC, Teixeira J et al. The influence of biosurfactants from probiotic bacteria on the formation of voice prosthetic biofilms. Appl Env Microbiol 2004; 70:4408-4410. (Pubitemid 38969794)
71. Rodrigues LR, Van der Mei HC, Banat IM et al. Inhibition of microbial adhesion to silicone rubber treated with biosurfactant from streptococcus thermophilus A. FEMS Immunol Med Microbiol 2004; 6:107-125.
72. Busscher HJ, Van Hoogmoed CG, Geertsema Doornbusch GI et al. Streptococcus thermophilus and its biosurfactants inhibit adhesion by candida spp on silicone rubber. Appl Env Microbiol 1997; 63:3810-3817. (Pubitemid 27411332)
73. Busscher HJ, Van de Belt-Gritter B, Westerhof M et al. Microbial interference in the colonization of silicone rubber implant surfaces in the oropharynx: Streptococcus thermophilus against a mixed fungal bacterial biofilm. In: Rosenberg E, ed. Microbial Ecology and Infectious Disease. Washington DC: American Society for Microbiology, 1999:66-74.
74. Pratt Terpstra IH, Weerkamp AH, Busscher HJ. Microbial factors in a thermodynamic approach of oral streptococcal adhesion to solid substrata. J Col Int Sci 1989; 129:568-574.
75. Van Hoogmoed CG, Van der Kuijl Booij M, Van der Mei HC et al. Inhibition of streptococcus mutans NS adhesion to glass with and without a salivary conditioning film by biosurfactant-releasing streptococcus mitis strain. Appl Env Microbiol 2000; 66:659-663. (Pubitemid 30082755)
76. Velraeds M, Van der Mei HC, Reid G et al. Inibition of initial adhesion of uropathogenic enterococcus faecalis to solid substrata by an adsorbed biosurfactant layer from Lactobacillus acidophilus. Urology 1997; 49:790-794. (Pubitemid 27194604)
77. Reid G, Zalai C, Gardiner G. Urogenital Lactobacilli probiotics, reliability and regulatory issues. J Dairy Sci 1984; 84:164-169.
78. Reid G, Heinemann C, Velraeds M et al. Biosurfactants produced by lactobacillus. Methods Enzymol 1999; 310:426-433. (Pubitemid 29504295)
79. Velraeds M, Van der Mei HC, Reid G et al. Physicochemical and biochemical characterization of biosurfactants released by Lactobacillus strains. Colloids Surf B Biointerfaces 1996; 8:51-61. (Pubitemid 26426609)
80. Velraeds M, Van der Mei HC, Reid G et al. Inhibition of initial adhesion of uropathogenic enterococcus faecalis by biosurfactants from lactobacillus isolates. Appl Env Microbiol 1996; 62:1958-1963. (Pubitemid 26168987)
81. Gotek P, Bednarski W, Lewandowska M. Characterization of adhesive properties of lactobacillus strains synthesising biosurfactants. Polish J Nat Sci 2007; 22:333-342.
82. Rodrigues LR, Van der Mei HC, Teixeira J et al. Biosurfactant from lactococcus lactis 53 inhibit microbial adhesion on silicone rubber. Appl Microbiol Biotechnol 2004; 66:306-311. (Pubitemid 40064362)
83. Kikuchi T, Hasumi K. Enhancement of reciprocal activation of prourokinase plasminogen by the bacterial lipopeptide surfactins and iturins. J Antibiot 2003; 56:34-37. (Pubitemid 36193275)
84. Van Bogaert INA, Saerens K, De Muynck C et al. Microbial production and application of sophorolipids. Appl Microbiol Biotechnol 2007; 76:23-34. (Pubitemid 47194681)
85. Sudo T, Zhao X, Wakamatsu Y et al. Induction of the differentiation of human HL-60 promyelocytic leukemia cell line by succinoyl trehalose lipids. Cytotechnol 2000; 33:259-264.
86. Im J, Nakane T, Yanagishita H et al. Mannosylerythritol lipid, a yeast extracellular glycolip, shows high binding affinity towards human immunoglobulin G. BMC Biotechnol 2001;1:1-5.
87. Im JH, Yanagishita H, Ikegami T et al. Mannosylerythritol lipids, yeast glycolipid biosurfactants, are potential affinity ligand materials for human immunoglobulin G. J Biomed Mat Res 2003; 65:379-385. (Pubitemid 37517274)
88. Inoh Y, Kitamoto D, Hirashima N et al. Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes. Biochem Biophys Res Comm 2001; 289:57-61. (Pubitemid 33108791)
89. Inoh Y, Kitamoto D, Hirashima N et al. Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion. J Contr Release 2004; 94:423-431. (Pubitemid 38117152)
90. Kitamoto D, Isoda H, Nakahara T. Functions and potential applications of glycolipid biosurfactants- from energy-saving materials to gene delivery carriers. J Biosci Bioeng 2002; 94:187-201. (Pubitemid 35192064)
91. Wright JR. Pulmonary surfactant: A front line of lung host defense. J Clin Inv 2003; 111:1453-1455. (Pubitemid 38063275)
92. Sano H, Sohma H, Muta T et al. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 1999; 163:387-395. (Pubitemid 29295865)
93. Sen R, Swaminathan T. Characterization of concentration and purification parameters and operating conditions for the small-scale recovery of surfactin. Proc Biochem 2005; 40:2953-2958. (Pubitemid 41009191)
94. Carrillo C, Teruel J, Aranda F et al. Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin. Biochim Biophys Acta 2003; 1611:91-97. (Pubitemid 36351436)
95. Kim K, Jung SY, Lee DK et al. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochem Pharmacol 1998; 55:975-985. (Pubitemid 28167719)
96. Kikuchi T, Hasumi K. Enhancement of plasminogen activation by surfactin C: Augmentation of fibrinolysis in vitro and in vivo. Biochim Biophys Acta 2002; 1596:234-245. (Pubitemid 34455050)
97. Moyne AL, Shelby R, Cleveland TE et al. Bacillomycin D: An iturin with antifungal activity against aspergillus flavus. J Appl Microbiol 2001; 90:622-629. (Pubitemid 32291264)
98. Kosaric N. Biosurfactants. In: Rehm HJ, Reed G, Puhler A et al, eds. Biotechnology. P. Weinheim VCH 1996:659-717.
99. Nielsen T, Christophersen C, Anthoni U et al. Viscosinamide, a new cyclic depsipeptide with surfactant and antifungal properties produced by pseudomonas fluorescens DR54. J Appl Microbiol1999; 86:80-90. (Pubitemid 29325535)
100. Neu T, Hartner T, Poralla K. Surface active properties of viscosin: A peptidolipid antibiotic. Appl Microbiol Biotechnol 1990; 32:518-20. (Pubitemid 20126038)
101. Bidel DJ, Aly R, Shinefield HR. Inhibition of microbial adherence by sphinganine. Can J Microbiol 1992; 38:983-985.
102. Van Delden C, Iglewski B. Cell-to-cell signaling and pseudomonas aeruginosa infections. Emerg Infect Dis 1998; 4:551-560. (Pubitemid 28553680)
103. Ishigami Y, Suzuki S. Development of biochemicals-functionalization of biosurfactants and natural dyes. Prog Organ Coat 1997; 31:51-61. (Pubitemid 127405835)
104. Ramisse F, Delden C, Gidenne S et al. Decreased virulence of a strain of pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 b-lactamase could be due to reduced expression of cell-to-cell signalling dependent virulence factors. FEMS Immunol Med Microbiol 2000; 28:241-245. (Pubitemid 32939407)
105. Sotirova A, Spasova D, Vasileva Tonkova E et al. Effects of rhamnolipid-biosurfactant on cell surface of pseudomonas aeruginosa. Microbiol Res 2007; In press.
106. Mireles JR, Toguchi A, Harshey RM. Salmonella enterica serovar typhimurium swarming mutants with altered biofilm formation abilities: Surfactin inhibits biofilm formation. J Bacteriol 2001; 183:5848-5854. (Pubitemid 32917402)
107. Boris S, Barbés C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000; 2:543-546. (Pubitemid 30387208)
108. Velraeds M, Van de Belt Gritter B, Van der Mei HC et al. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998; 47:1081-1085. (Pubitemid 28534829)
109. Reid G. In vitro testing of Lactobacillus acidophilus NCFM as a possible probiotic for the urogenital tract. Int Dairy J 2000; 10:415-419.
110. Heinemann C, Van Hylckama V, Janssen D et al. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiol Lett 2000; 190:177-180. (Pubitemid 30645855)
111. Cameotra S, Makkar R. Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 2004; 7:262-266. (Pubitemid 38758067)
112. Reid G, Bruce A, Smeianov V. The role of Lactobacilli in preventing urogenital and intestinal infections. Inter Dairy J 1998; 8:555-562. (Pubitemid 28504157)
113. Reid G, Bruce A, Fraser N et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30:49-52. (Pubitemid 32145004)
114. Gan B, Kim J, Reid G et al. Lactobacillus fermentum RC-14 inhibits staphylococcus aureus infection of surgical implants in rats. J Infect Dis 2002; 185:1369-1372. (Pubitemid 34439150)
115. Mack DR, Michail S, Wei S et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276:941-950.
116. Millsap K, Reid G, Van der Mei HC et al. Adhesion of Lactobacillus species in urine and phosphate buffer to silicone rubber and glass under flow. Biomaterials 1996; 18:87-91. (Pubitemid 27029722)